BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26126921)

  • 1. Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells.
    Wang X; Wu G; Cao G; Yang L; Xu H; Huang J; Hou J
    Mol Med Rep; 2015 Sep; 12(3):4620-4625. PubMed ID: 26126921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation.
    Jiang P; Du W; Yang X
    Cell Cycle; 2013 Dec; 12(24):3720-6. PubMed ID: 24270845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.
    Dulloo I; Hooi PB; Sabapathy K
    Cell Cycle; 2015; 14(22):3533-9. PubMed ID: 26267146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.
    Okamoto S; Kawamura K; Li Q; Yamanaka M; Yang S; Fukamachi T; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Kobayashi H; Tagawa M
    J Thorac Oncol; 2012 May; 7(5):873-82. PubMed ID: 22481236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
    Chen X; Xu Z; Zhu Z; Chen A; Fu G; Wang Y; Pan H; Jin B
    Int J Oncol; 2018 Oct; 53(4):1703-1712. PubMed ID: 30066842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAp73 enhances the pentose phosphate pathway and supports cell proliferation.
    Du W; Jiang P; Mancuso A; Stonestrom A; Brewer MD; Minn AJ; Mak TW; Wu M; Yang X
    Nat Cell Biol; 2013 Aug; 15(8):991-1000. PubMed ID: 23811687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
    Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
    Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
    Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
    Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAp73 promotes anti-senescence-anabolism not proliferation.
    Agostini M; Niklison-Chirou MV; Catani MV; Knight RA; Melino G; Rufini A
    Aging (Albany NY); 2014 Nov; 6(11):921-30. PubMed ID: 25554796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis.
    Shan C; Lu Z; Li Z; Sheng H; Fan J; Qi Q; Liu S; Zhang S
    Cell Death Dis; 2019 Jul; 10(7):525. PubMed ID: 31285420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
    Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
    FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Role of Dickkopf-Related Protein 3 in Macropinocytosis in Human Bladder Cancer T24 Cells.
    Tsujimura N; Yamada NO; Kuranaga Y; Kumazaki M; Shinohara H; Taniguchi K; Akao Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAG3 elevation inhibits cell proliferation via direct interaction with G6PD in hepatocellular carcinomas.
    Kong DH; Li S; Du ZX; Liu C; Liu BQ; Li C; Zong ZH; Wang HQ
    Oncotarget; 2016 Jan; 7(1):700-11. PubMed ID: 26621836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
    Zhang P; Liu SS; Ngan HY
    PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
    Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
    Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.